Susquehanna International Group
ANIX icon

Susquehanna International Group’s Anixa Biosciences ANIX Stock Holding History

Susquehanna International Group’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$23.2K – 12404
2024
Q4 		$23.2K Buy
+10,000
New +$31.1K ﹤0.01% 11894
2024
Q2 		– Sell
-20,200
Closed -$63K – 11968
2024
Q1 		$63K Sell
20,200
-13,300
-40% -$53K ﹤0.01% 11462
2023
Q4 		$130K Buy
+33,500
New +$113K ﹤0.01% 11106
2022
Q4 		– Sell
-13,000
Closed -$64K – 12322
2022
Q3 		$64K Buy
13,000
+100
+0.8% +$405 ﹤0.01% 12041
2022
Q2 		$39K Buy
+12,900
New +$40.7K ﹤0.01% 12102
2022
Q1 		– Sell
-14,600
Closed -$43K – 12918
2021
Q4 		$43K Sell
14,600
-25,100
-63% -$101K ﹤0.01% 12617
2021
Q3 		$189K Buy
+39,700
New +$179K ﹤0.01% 11548

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Susquehanna International Group's ANIX Position: Q1 2026 in Review

Susquehanna International Group reduced its Anixa Biosciences (ANIX) stake by 61% in Q1 2026, selling an estimated $452K and leaving 99,468 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #11211.

Susquehanna International Group first reported a position in ANIX in Q3 2015 and has held it in 20 quarters since. The position peaked at $1.06M in Q1 2024. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Susquehanna International Group held 99,468 shares of Anixa Biosciences worth $257K as of Q1 2026.
  • Susquehanna International Group sold 152,606 Anixa Biosciences shares in Q1 2026, an estimated $452K.
  • Anixa Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11211 holding.
  • Susquehanna International Group first reported a position in Anixa Biosciences in Q3 2015 and has held it in 20 quarters since.
  • Susquehanna International Group's Anixa Biosciences position peaked at $1.06M in Q1 2024.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.